Magnetic resonance imaging parameters in predicting the ablative efficiency of high-intensity focused ultrasound for uterine fibroids

References

• Baird DD, David BD, Michael CH, et al. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol. 2003;188:100–107.
   PubMed Web of Science ®Google Scholar
• Clarke-Pearson DL, Geller EJ. Complications of hysterectomy. Obstet Gynecol. 2013;121(3):654–673.
   PubMed Web of Science ®Google Scholar
• Toor SS, Jaberi A, Macdonald DB, et al. Complication rates and effectiveness of uterine artery embolization in the treatment of symptomatic leiomyomas: a systematic review and meta-analysis. AJR Am J Roentgenol. 2012;199(5):1153–1163.
   PubMed Web of Science ®Google Scholar
• Nishiyama S, Saito M, Sato K, et al. High recurrence rate of uterine fibroids on transvaginal ultrasound after abdominal myomectomy in Japanese women. Gynecol Obstet Invest. 2006;61(3):155–159.
   PubMed Web of Science ®Google Scholar
• Froeling V, Meckelburg K, Scheurig-Muenkler C, et al. Midterm results after uterine artery embolization versus MR-guided high-intensity focused ultrasound treatment for symptomatic uterine fibroids. Cardiovasc Intervent Radiol. 2013;36(6):1508–1513.
   PubMed Web of Science ®Google Scholar
• Liu X, Tang J, Luo Y, et al. Comparison of high-intensity focused ultrasound ablation and secondary myomectomy for recurrent symptomatic uterine fibroids following myomectomy: a retrospective study. BJOG: Int J Obstet Gynecol. 2020;127:1422–1428.
   PubMed Web of Science ®Google Scholar
• Chen J, Li Y, Wang Z, et al. Evaluation of high-intensity focused ultrasound ablation for uterine fibroids: an IDEAL prospective exploration study. BJOG: Int J Obstet Gynaecol. 2018;125(3):354–364.
   PubMed Web of Science ®Google Scholar
• Li W, Jiang Z, Deng X, et al. Long-term follow-up outcome and reintervention analysis of ultrasound-guided high intensity focused ultrasound treatment for uterine fibroids. International journal of hyperthermia: the official journal of European Society for Hyperthermic Oncology. Int J Hyperthermia. 2020;37(1):1046–1051.
   PubMed Web of Science ®Google Scholar
• Mindjuk I, Trumm CG, Herzog P, et al. MRI predictors of clinical success in MR-guided focused ultrasound (MRgFUS) treatments of uterine fibroids: results from a single centre. Eur Radiol. 2015;25(5):1317–1328.
   PubMed Web of Science ®Google Scholar
• Keserci B, Duc NM. The role of T1 perfusion-based classification in magnetic resonance-guided high-intensity focused ultrasound ablation of uterine fibroids. Eur Radiol. 2017;27(12):5299–5308.
   PubMed Web of Science ®Google Scholar
• Cheng H, Wang C, Tian J. Correlation between uterine fibroids with various magnetic resonance imaging features and therapeutic effects of high-intensity focused ultrasound ablation. Pak J Med Sci. 2015;31:869–873.
   PubMed Web of Science ®Google Scholar
• Thiburce AC, Frulio N, Hocquelet A, et al. Magnetic resonance-guided high-intensity focused ultrasound for uterine fibroids: mid-term outcomes of 36 patients treated with the Sonalleve system. Int J Hyperthermia. 2015;31(7):764–770.
   PubMed Web of Science ®Google Scholar
• Kim Y-s, Lim HK, Park MJ, et al. Screening magnetic resonance imaging-based prediction model for assessing immediate therapeutic response to magnetic resonance imaging-guided high-intensity focused ultrasound ablation of uterine fibroids. Invest Radiol. 2016;51(1):15–24.
   PubMed Web of Science ®Google Scholar
• Kim Y-s, Lee J-W, Choi CH, et al. Uterine fibroids: correlation of T2 signal intensity with semiquantitative perfusion MR parameters in patients screened for MR-guided high-intensity focused ultrasound ablation. Radiology. 2016;278(3):925–935.
   PubMed Web of Science ®Google Scholar
• Park JJ, Kim CK, Park SY, et al. Assessment of early response to concurrent chemoradiotherapy in cervical cancer: value of diffusion-weighted and dynamic contrast-enhanced MR imaging. Magn Reson Imaging. 2014;32(8):993–1000.
   PubMed Web of Science ®Google Scholar
• Kim Y-s, Kim B-G, Rhim H, et al. Uterine fibroids: semiquantitative perfusion MR imaging parameters associated with the intraprocedural and immediate postprocedural treatment efficiencies of MR imaging–guided high-intensity focused ultrasound ablation. Radiology. 2014;273(2):462–471.
   PubMed Web of Science ®Google Scholar
• Suomi V, Komar G, Sainio T, et al. Comprehensive feature selection for classifying the treatment outcome of high-intensity ultrasound therapy in uterine fibroids. Sci Rep. 2019;9(1):10907.
   PubMed Web of Science ®Google Scholar
• Liu Z, Gong C, Liu Y, et al. Establishment of a scoring system for predicting the difficulty level of high-intensity focussed ultrasound ablation of uterine fibroids. Int J Hyperthermia. 2018;34(1):77–86.
   PubMed Web of Science ®Google Scholar
• Funaki K, Fukunishi H, Funaki T, et al. Magnetic resonance-guided focused ultrasound surgery for uterine fibroids: relationship between the therapeutic effects and signal intensity of pre-existing T2-weighted MR images. Am J Obstet Gynecol. 2007;196(2):184.e181–184.e186.
   Google Scholar
• Ronit M, Yael I, Shlomo CE, et al. MR-guided focus ultrasound (MRgFUS) for symptomatic uterine fibroids: predictors of treatment success†. Hum Reprod. 2012;27:3425–3431.
   PubMed Web of Science ®Google Scholar
• Ikink ME, Voogt MJ, Verkooijen HM, et al. Mid-term clinical efficacy of a volumetric magnetic resonance-guided high-intensity focused ultrasound technique for treatment of symptomatic uterine fibroids. Eur Radiol. 2013;23(11):3054–3061.
   PubMed Web of Science ®Google Scholar
• Ikink ME, van Breugel JMM, Schubert G, et al. Volumetric MR-guided high-intensity focused ultrasound with direct skin cooling for the treatment of symptomatic uterine fibroids: proof-of-concept study. Proc Int Soc Magn Reson Med. 2014;2014:684250.
   Google Scholar
• Baker KG, Robertson VJ, Duck FA. A review of therapeutic ultrasound: biophysical effects. Phys Ther. 2001;81(7):1351–1358.
   PubMed Web of Science ®Google Scholar
• Divya S, Kohi M. Updates on MR-guided focused ultrasound for symptomatic uterine fibroids. Semin Intervent Radiol. 2018;35(1):17–22.
   PubMed Web of Science ®Google Scholar
• Trimboli P, Bini F, Marinozzi F, et al. High-intensity focused ultrasound (HIFU) therapy for benign thyroid nodules without anesthesia or sedation. Endocrine. 2018;61(2):210–215.
   PubMed Web of Science ®Google Scholar
• Fan H-J, Cun J-P, Zhao W, et al. Factors affecting effects of ultrasound guided high intensity focused ultrasound for single uterine fibroids: a retrospective analysis. Int J Hyperthermia. 2018;35(1):534–540.
   PubMed Web of Science ®Google Scholar
• Fan H-J, Zhang C, Lei H-T, et al. Ultrasound-guided high-intensity focused ultrasound in the treatment of uterine fibroids. Medicine. 2019;98(10):e14566.
   PubMed Web of Science ®Google Scholar
• Chen L, Haar GT, Hill CR. Influence of ablated tissue on the formation of high-intensity focused ultrasound lesions. Ultrasound Med Biol. 1997;23(6):921–931.
   PubMed Web of Science ®Google Scholar